Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-01-08 4:18 pm Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | Avidity Partners Management LP | 6,360,212 7.2% | 6,360,212 (New Position) | View |
2023-10-23 5:20 pm Purchase | 13G | FUSION PHARMACEUTICALS INC FUSN | Avidity Partners Management LP | 6,824,450 9.7% | 6,824,450 (New Position) | View |
2023-05-25 11:20 am Purchase | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | Avidity Partners Management LP | 2,950,000 6.2% | 2,950,000 (New Position) | View |
2023-02-14 4:19 pm Purchase | 13G | PROTHENA CORP PLC SHS PRTA | Avidity Partners Management LP | 2,953,000 5.7% | 2,953,000 (New Position) | View |
2023-02-14 4:07 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Avidity Partners Management LP | 2,189,719 9.9% | 69,719 (+3.29%) | View |
2023-02-14 3:59 pm Purchase | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 3,624,523 9.9% | 1,385,245 (+61.86%) | View |
2023-02-14 3:52 pm Sale | 13G | ESSA PHARMA INC EPIX | Avidity Partners Management LP | 1,855,400 4.2% | -1,894,600 (-50.52%) | View |
2023-02-14 3:49 pm Purchase | 13G | ALTIMMUNE INC ALT | Avidity Partners Management LP | 3,990,000 8.1% | 1,225,000 (+44.30%) | View |
2023-02-14 3:47 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Avidity Partners Management LP | 6,718,142 9.7% | 1,474,123 (+28.11%) | View |
2023-02-14 3:44 pm Purchase | 13G | KEZAR LIFE SCIENCES INC KZR | Avidity Partners Management LP | 6,782,400 9.9% | 3,554,200 (+110.10%) | View |
2023-02-14 3:39 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Avidity Partners Management LP | 3,824,800 7.9% | 1,271,800 (+49.82%) | View |
2023-02-14 3:38 pm Sale | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Avidity Partners Management LP | 1,888,887 4% | -316,800 (-14.36%) | View |
2023-02-14 3:31 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Avidity Partners Management LP | 11,381,073 9.9% | 29,254 (+0.26%) | View |
2023-02-14 3:23 pm Sale | 13G | GRITSTONE BIO INC GRTS | Avidity Partners Management LP | 2,859,971 3.3% | -4,130,223 (-59.09%) | View |
2023-02-14 2:58 pm Purchase | 13G | AKERO THERAPEUTICS INC AKRO | Avidity Partners Management LP | 3,825,000 8.2% | 720,000 (+23.19%) | View |
2023-02-14 2:42 pm Sale | 13G | CYTEIR THERAPEUTICS INC CYT | Avidity Partners Management LP | 1,795,800 5.1% | -53,738 (-2.91%) | View |
2023-02-14 2:26 pm Sale | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Avidity Partners Management LP | 2,040,000 4.1% | -2,365,000 (-53.69%) | View |
2023-02-14 1:58 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Avidity Partners Management LP | 1,900,000 4.6% | 4,000 (+0.21%) | View |
2023-02-14 1:38 pm Purchase | 13G | ARVINAS INC ARVN | Avidity Partners Management LP | 4,950,000 9.3% | 1,710,162 (+52.79%) | View |
2023-02-14 1:10 pm Sale | 13G | IVERIC BIO INC ISEE | Avidity Partners Management LP | 838,407 0.6% | -6,116,593 (-87.95%) | View |